A detailed history of Kerr Financial Planning Corp transactions in Eli Lilly & CO stock. As of the latest transaction made, Kerr Financial Planning Corp holds 143 shares of LLY stock, worth $146,103. This represents 0.21% of its overall portfolio holdings.

Number of Shares
143
Holding current value
$146,103
% of portfolio
0.21%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 25, 2025

BUY
$625.65 - $812.69 $89,467 - $116,214
143 New
143 $147 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $971B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Kerr Financial Planning Corp Portfolio

Follow Kerr Financial Planning Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kerr Financial Planning Corp, based on Form 13F filings with the SEC.

News

Stay updated on Kerr Financial Planning Corp with notifications on news.